Accueil
Détail de l'indexation
MAL : Maladies infectieuses / Infectious diseases |
Ouvrages de la bibliothèque en indexation MAL (1752)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : Périodique
We review evidence for effectiveness, cost-effectiveness, and coverage of antiretroviral therapy (ART) for injecting drug users (IDUs) infected with HIV, with particular attention to low-income and middle-income countries. In these countries, ne[...]Article : Périodique
I. GOUNTAS ; V. SYPSA ; O. ANAGNOSTOU ; N. MARTIN ; P. VICKERMAN ; E. KAFETZOPOULOS ; A. HATZAKIS |Aims: To project the impact of scaling-up oral anti-viral therapy and harm reduction on chronic hepatitis C (CHC) prevalence and incidence among people who inject drugs (PWID) in Greece, to estimate the relationship between required treatment le[...]NouveautéArticle : Périodique
D. WERB ; E. WOOD ; T. KERR ; N. HERSHFIELD ; R. W. H. PALMER ; R. S. REMIS |Background Canadian injection drug users (IDUs) are at high risk of hepatitis C virus infection (HCV). However, little is known about the costs associated with their HCV-related medical treatment. We estimated the medical costs of treating HCV-i[...]Article : Périodique
B. FISCHER ; J. REIMER ; FIRESTONE M. ; KALOUSEK K. ; J. REHM ; HEATHCOTE J. |Illicit drug users are the primary risk group for HCV transmission, and will form the largest HCV treatment population for years to come. Sylvestre et al.'s study suggests that cannabis use may benefit treatment retention and outcomes in illicit[...]Article : Périodique
It is currently estimated that between 2.7 million and 4.0 million persons in the United States have chronic hepatitis C virus (HCV) infection. Many of these persons have potentially progressive disease. Studies suggest that mortality and health[...]Périodique
O. DALGARD ; K. BJORO ; HELLUM K. ; MYRVANG B. ; SKAUG K. ; GUTIGARD B. ; H. BELL ; CONSTRUCT GROUP | 2002ENGLISH : Aim of the Study: To assess the long-term hepatitis C (HCV) treatment outcome in former injecting drug users (IDUs). Materials and Methods:A long-term follow-up of 27 former IDUs who had been successfully treated for chronic hepatiti[...]Périodique
M. SCHAEFER ; A. HEINZ ; M. BACKMUND | 2004ENGLISH : Aims : Approximately 170 million people world-wide are chronically infected with the hepatitis C virus (HCV). While the seroprevalence in the general population ranges between 0.2 and 2% 50-90% of injection drug users are chronically[...]Périodique
M. P. MANNS ; H. WEDEMEYER | 2004In the modern era of highly active antiretroviral therapy (HAART), hepatitis C virus (HCV) has emerged as a major cause of morbidity and death in human immunodeficiency virus (HIV) infection. An estimated 15% to 30% of HIV-infected individuals a[...]Article : Périodique
E. ASPINALL ; S. CORSON ; J. S. DOYLE ; J. GREBELY ; S. J. HUTCHINSON ; G. J. DORE ; D. J. GOLDBERG ; M. E. HELLARD |BACKGROUND: Although guidelines recommend that people who inject drugs (PWID) should not be excluded from hepatitis C (HCV) treatment, some services remain reluctant to treat PWID. The aim of this review was to investigate sustained virologic re[...]Article : Périodique
HIV-infected drug users have increased age-matched morbidity and mortality compared with HIV-infected people who do not use drugs. Substance-use disorders negatively affect the health of HIV-infected drug users, who also have frequent medical an[...]Périodique
D. GOLDBERG ; S. BURNS ; A. TAYLOR ; S. CAMERON ; HARGREAVES D. ; S. HUTCHINSON | 2001ENGLISH : In 1998, we reported that anti-HCV prevalence among injectors from Glasgow had declined between 1990 and 1995. We set out to ascertain if the anti-HCV prevalence among injectors from Edinburgh had declined similarly during this perio[...]Article : Périodique
Data on newly diagnosed HIV infections and HIV prevalence in 2005 to 2010 suggest falling infection rates in injecting drug users (IDUs) in the European Union (EU). However, recent increases in HIV and hepatitis C virus (HCV) infection rates in [...]Article : Périodique
Persons who engage in unprotected sexual intercourse or use injection drugs are at increased risk for human immunodeficiency virus (HIV) infection and sexually transmitted diseases (STDs). Changes in HIV- and STD-related risk behaviors among hig[...]Périodique
Trends in HIV risk behaviour and methadone dosage among HIV-negative drug users: an ecological study
FRANÇAIS : Des études internationales ont suggéré que le traitement de maintenance à la méthadone peut diminuer la propagation du VIH chez les héroïnomanes lorsque la posologie du traitement est adéquate (> 60mg/jour). Cette étude explore les c[...]Article : Périodique
A. H. KRAL ; J. LORVICK ; L. GEE ; P. BACCHETTI ; RAWAL B. ; M. BUSCH ; B. R. EDLIN |This paper reports trends in human immunodeficiency virus (HIV) incidence among street-recruited injection drug users (IDUs) in San Francisco, California, from 1987 through 1998, estimated using a sensitive/less sensitive enzyme immunoassay test[...]